These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 3828800)
1. The characterization of [3H]sulpiride binding sites in rat striatal membranes. Imafuku J Brain Res; 1987 Feb; 402(2):331-8. PubMed ID: 3828800 [TBL] [Abstract][Full Text] [Related]
2. The characterization of [3H]sulpiride binding sites in pig striatal membranes. Holden-Dye L; Poat JA; Senior K; Woodruff GN Biochem Pharmacol; 1985 Aug; 34(16):2905-9. PubMed ID: 4026877 [TBL] [Abstract][Full Text] [Related]
3. Cation specificity of 3H-sulpiride binding involves alteration in the number of striatal binding sites. Theodorou AE; Jenner P; Marsden CD Life Sci; 1983 Mar; 32(11):1243-54. PubMed ID: 6834988 [TBL] [Abstract][Full Text] [Related]
4. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Hamblin MW; Leff SE; Creese I Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712 [TBL] [Abstract][Full Text] [Related]
5. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations. Freedman SB; Poat JA; Woodruff GN J Neurochem; 1981 Sep; 37(3):608-12. PubMed ID: 7276943 [TBL] [Abstract][Full Text] [Related]
6. Regulation of agonist binding to A2A adenosine receptors: effects of guanine nucleotides (GDP[S] and GTP[S]) and Mg2+ ion. Mazzoni MR; Martini C; Lucacchini A Biochim Biophys Acta; 1993 Dec; 1220(1):76-84. PubMed ID: 8268248 [TBL] [Abstract][Full Text] [Related]
7. Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands. Urwyler S; Coward D Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):115-22. PubMed ID: 2951601 [TBL] [Abstract][Full Text] [Related]
8. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. Zahniser NR; Dubocovich ML J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559 [TBL] [Abstract][Full Text] [Related]
9. 3H-dopamine binding to rat striatal D-2 and D-3 sites: enhancement by magnesium and inhibition by guanine nucleotides and sodium. Hamblin MW; Creese I Life Sci; 1982 May; 30(18):1587-95. PubMed ID: 7078356 [TBL] [Abstract][Full Text] [Related]
10. Influence of sodium and sulphydryl groups on [3H]sulpiride binding sites in rat striatal membranes. Freedman SB; Poat JA; Woodruff GN J Neurochem; 1982 May; 38(5):1459-65. PubMed ID: 7062062 [TBL] [Abstract][Full Text] [Related]
11. [3H]Ro 22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner. Nakajima T; Iwata K Mol Pharmacol; 1984 Nov; 26(3):430-8. PubMed ID: 6149457 [TBL] [Abstract][Full Text] [Related]
12. Effects of proteolytic enzymes and monovalent ions demonstrate protease-sensitive and protease-insensitive stereospecific binding sites on dopaminergic receptors in rat striatum. Leysen JE; Van Gompel P Biochem Pharmacol; 1982 Apr; 31(7):1343-55. PubMed ID: 7046754 [TBL] [Abstract][Full Text] [Related]
13. Hepatic vasopressin receptor: differential effects of divalent cations, guanine nucleotides, and N-ethylmaleimide on agonist and antagonist interactions with the V1 subtype receptor. Gopalakrishnan V; McNeill JR; Sulakhe PV; Triggle CR Endocrinology; 1988 Aug; 123(2):922-31. PubMed ID: 2969327 [TBL] [Abstract][Full Text] [Related]
14. Role of assay conditions in determining agonist potency at D2 dopamine receptors in striatal homogenates. de Vries DJ; Beart PM Brain Res; 1986 Jul; 387(1):29-35. PubMed ID: 3742232 [TBL] [Abstract][Full Text] [Related]
15. Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride. Reader TA; Boulianne S; Molina-Holgado E; Dewar KM Biochem Pharmacol; 1990 Oct; 40(8):1739-46. PubMed ID: 2146961 [TBL] [Abstract][Full Text] [Related]
16. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum. Zahniser NR; Molinoff PB Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199 [TBL] [Abstract][Full Text] [Related]
17. Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals. Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK Synapse; 1988; 2(5):521-31. PubMed ID: 2973146 [TBL] [Abstract][Full Text] [Related]
18. Characterization of stereospecific binding of 3H-(-) sulpiride, a selective antagonist at dopamine-D2 receptors, in rat CNS. Memo M; Govoni S; Carboni E; Trabucchi M; Spano PF Pharmacol Res Commun; 1983 Feb; 15(2):191-9. PubMed ID: 6844376 [TBL] [Abstract][Full Text] [Related]
19. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Graham WC; Crossman AR; Woodruff GN Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410 [TBL] [Abstract][Full Text] [Related]
20. Ca2(+)-dependent, ATP-induced conversion of the [3H]hemicholinium-3 binding sites from high- to low-affinity states in rat striatum: effect of protein kinase inhibitors on this affinity conversion and synaptosomal choline transport. Chatterjee TK; Bhatnagar RK J Neurochem; 1990 May; 54(5):1500-8. PubMed ID: 2324736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]